LifeScience

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development

Synexa Life Sciences BV, a global leader in specialist biomarker and bioanalysis research services, has today announced that it...

 May 20, 2022 | News

GenScript Launches GMP Single-Strand and Double-Strand DNA Service for Supporting Gene and Cell Therapy Development

 GenScript USA Inc., the world's leading life-science research tools and services provider, announced the availability of new GMP-grade ...

 May 17, 2022 | News

GenScript ProBio Establishes Korean Legal Entity and Further Strengthens Cooperation in South Korea and APAC Region

During the BIO KOREA 2022, Dr. Brian H. Min, CEO of GenScript ProBio, introduced the development history of GenScript ProBio to the participants and o...

 May 13, 2022 | News

Merck aims to significantly reduce its greenhouse gas emissions by 2030

Merck, a leading science and technology company, aims to significantly reduce its greenhouse gas emissions by 2030. The independent Science Based Targ...

 May 10, 2022 | News

SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer

SCG101 is the first TCR-T cell therapy product to receive a multi-regional Investigational New Drug (IND) approval from Singapore's Health Scie...

 May 09, 2022 | News

Merck’s First-Asia Pacific Mobius® Single-Use Manufacturing Center in Wuxi, China

Investment Supports Biotech Innovation in China Partnership with Administrative Management Committee of Wuxi National High-Tech Industrial Development Z...

 May 06, 2022 | News

Matica Bio Opens New Cell and Gene Therapy GMP Facility in Texas

Cell and Gene Therapy Specialty Building on years of cell and gene therapy expertise, Matica Bio’s new facility is now expanding its capacity as a C...

 May 04, 2022 | News

Biocytogen Enters into Antibody Agreement with Merck

Under the agreement, Biocytogen will provide Merck antibodies directed against at least three targets specified by them from Biocytogen's Project Integrum&...

 May 02, 2022 | News

Seegene unveils world's first commercialized '3 Ct' PCR assay

"Dream MDx technology" developed based on Seegene's 20-year expertise; combines 19 different patented technologies, including DPO™, TOCE™, Mu...

 April 27, 2022 | News

Thermo Fisher opens bioprocessing manufacturing facility in Ogden, UT

Thermo Fisher Scientific today celebrated the opening of its new single-use technology manufacturing site in Ogden, Utah. The state-of-the-art facility cre...

 April 21, 2022 | News

MGI announces partnership with Nalagenetics to advance personalized medicine

MGI, a company committed to being a world-leading life science innovator, today announced a partnership with Nalagenetics (NALA) to co-develop lo...

 April 19, 2022 | News

Agilent Joins AMBIC to Advance Biomanufacturing

Agilent Technologies Inc. (NYSE: A) announced today that it has become a member of the Advanced Mammalian Biomanufacturing Innovation Center (AMB...

 April 14, 2022 | News

HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies to Expand Growth Initiative

HanAll Biopharma (KRX: 009420.KS) and Daewoong Pharmaceutical (KRX: 069620.KS) today announced expansion of their open collaboration strategy by investing ...

 April 13, 2022 | News

Global pharma organizations back Turn Biotechnologies to advance its cell rejuvenation program

Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced that it clos...

 April 12, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close